-
DRC announces plans to use second Ebola vaccine
europeanpharmaceuticalreview
September 24, 2019
Health authorities in the Democratic Republic of Congo are planning to use a second vaccine to treat the Ebola virus.
-
Dengue virus becoming resistant to vaccines and therapeutics due to mutations in specific protein
worldpharmanews
September 23, 2019
Researchers from Duke-NUS Medical School (DukeNUS), in collaboration with the Agency for Science, Technology and Research (A*STAR)'s Bioinformatics Institute (BII) ...
-
FDA accepts Biologics License Application for V920 Ebola vaccine
europeanpharmaceuticalreview
September 20, 2019
A Biologics License Application and priority review has been approved by the FDA for an investigational Ebola vaccine.
-
New flu patch could lead to needle-free vaccination methods
europeanpharmaceuticalreview
September 18, 2019
New vaccine patch has showed no negative side effects and could lead to a replacement of needle-based vaccination methods.
-
Men Less Knowledgeable About HPV, HPV Vaccination
drugs
September 18, 2019
Men are less knowledgeable than women about human papillomavirus (HPV), HPV vaccination, and the correlation between HPV and cancer, according to a research letter published online in JAMA Pediatrics.
-
Kenya launches phased malaria vaccine pilot programme
europeanpharmaceuticalreview
September 17, 2019
Kenya has become the third African country to introduce the world’s first malaria vaccine into the country, in a phased pilot programme.
-
Room for Improvement Found in HPV Vaccine Delivery Practices
drugs
September 17, 2019
There are areas for improvement for pediatricians and family physicians (FPs) in recommendation and delivery methods for the human papillomavirus (HPV) vaccine, according to a study published online in Pediatrics.
-
California Passes Laws to Reduce Fake Medical Exemptions for Vaccines
drugs
September 12, 2019
Bills to reduce fake medical exemptions for school children's vaccinations were signed into law Monday by California Governor Gavin Newsom.
-
Herd Protection Against Oral HPV Infections Seen Among Men
drugs
September 12, 2019
In unvaccinated men aged 18 to 59 years, the prevalence of vaccine-type oral human papillomavirus (HPV) decreased between 2009 to 2010 and 2015 to 2016...
-
Respiratory virus vaccine receives breakthrough therapy designation
europeanpharmaceuticalreview
September 06, 2019
The FDA has awarded a breakthrough therapy designation to an investigational prophylactic vaccine to treat respiratory syncytial virus in seniors.